3rd generation glp 1 agonist Schematic illustration of monoagonists, dual agonists and triple PDB-101: Molecule of the Month:
Description
63 Furthermore, potential side effects like nausea or vomiting can lead to fluid loss, and dehydration can worsen common issues like constipation, fatigue, and headaches
95% CI, 0.37-0.73
A meta-analysis of 12 studies (that included ten cohort and two case-control studies) found no overall change in PDAC risk amongst GLP-1RA users
In the United States, a major health poll found that around 1 in 8 adults have used a GLP-1 medication , with approximately 6% currently taking one
Administered subcutaneously, it fits seamlessly into daily routines, requiring just a single injection per week
